{"component": "definition", "props": {"groups": [{"size": 7, "samples": [{"hash": "cnSVZKYNg2L", "uri": "https://www.nrc.gov/docs/ML1807/ML18073A109.pdf", "label": "www.nrc.gov", "score": 5.2470908165, "published": false}, {"hash": "ar2BZFmxUy7", "uri": "https://www.nrc.gov/docs/ML1610/ML16105A321.pdf", "label": "www.nrc.gov", "score": 5.2470908165, "published": false}], "snippet": "means factual inputs, data, models, analyses, technical information, or scientific assessments related to such disciplines as the behavioral and social sciences, public health and medical sciences, life and earth sciences, engineering, or physical sciences. This definition includes any communication or representation of knowledge (e.g., facts or data, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual forms). This definition includes information that NRC disseminates from its Web page but does not include the provision of hyperlinks on a Web page to information that others disseminate. This definition excludes opinions where NRC\u2019s presentation makes clear that an individual\u2019s opinion, rather than a statement of fact or of the agency\u2019s findings and conclusions, is being offered.", "snippet_links": [{"key": "technical-information", "type": "definition", "offset": [46, 67]}, {"key": "related-to", "type": "definition", "offset": [95, 105]}, {"key": "social-sciences", "type": "clause", "offset": [145, 160]}, {"key": "medical-sciences", "type": "clause", "offset": [180, 196]}, {"key": "physical-sciences", "type": "definition", "offset": [239, 256]}, {"key": "web-page", "type": "definition", "offset": [532, 540]}, {"key": "provision-of", "type": "clause", "offset": [566, 578]}, {"key": "to-information", "type": "clause", "offset": [604, 618]}, {"key": "an-individual", "type": "clause", "offset": [720, 733]}, {"key": "statement-of-fact", "type": "clause", "offset": [759, 776]}, {"key": "the-agency", "type": "clause", "offset": [783, 793]}, {"key": "findings-and-conclusions", "type": "clause", "offset": [796, 820]}], "hash": "b49851b70b20ae196641d549fb7d6bbd", "id": 1}, {"size": 6, "samples": [{"hash": "gPq1pm6N4QP", "uri": "/contracts/gPq1pm6N4QP#scientific-information", "label": "License Agreement (Onconova Therapeutics, Inc.)", "score": 24.5427780151, "published": true}, {"hash": "3wh7GLumI6q", "uri": "/contracts/3wh7GLumI6q#scientific-information", "label": "License Agreement (Onconova Therapeutics, Inc.)", "score": 24.4496917725, "published": true}, {"hash": "liHWw6cfBO1", "uri": "/contracts/liHWw6cfBO1#scientific-information", "label": "License Agreement (Onconova Therapeutics, Inc.)", "score": 24.3347015381, "published": true}], "snippet": "means any and all medical, toxicological, pharmacological, pre clinical, clinical and chemical data, specifications, medical uses, adverse reactions, formulation and quality control methods of or for the Compound and/or the Licensed Product, and further including without limitation all proprietary information submitted to relevant Regulatory Authorities to support a Drug Approval Application for and Marketing Approval of the Licensed Product in any country of the world.", "snippet_links": [{"key": "adverse-reactions", "type": "definition", "offset": [131, 148]}, {"key": "quality-control", "type": "clause", "offset": [166, 181]}, {"key": "licensed-product", "type": "definition", "offset": [224, 240]}, {"key": "including-without-limitation", "type": "clause", "offset": [254, 282]}, {"key": "information-submitted", "type": "clause", "offset": [299, 320]}, {"key": "relevant-regulatory-authorities", "type": "definition", "offset": [324, 355]}, {"key": "drug-approval-application", "type": "definition", "offset": [369, 394]}, {"key": "approval-of", "type": "clause", "offset": [413, 424]}, {"key": "the-world", "type": "definition", "offset": [464, 473]}], "hash": "2b9b15ee78d285331b280fcf2cbf3947", "id": 2}, {"size": 3, "samples": [{"hash": "gFIBkX1JmFq", "uri": "/contracts/gFIBkX1JmFq#scientific-information", "label": "Investor Rights Agreement (Acceleron Pharma Inc)", "score": 24.597536087, "published": true}, {"hash": "8XjsK6iVKtu", "uri": "/contracts/8XjsK6iVKtu#scientific-information", "label": "Investor Rights Agreement (Acceleron Pharma Inc)", "score": 24.5017108917, "published": true}], "snippet": "means any and all non-public scientific, technical, business or financial information, in whatever form (written, oral or visual) relating specifically to programs based on ActRIIA, such as ACE-011, programs based on ActRIIB, such as ACE-031, programs based on ALK-1, such as ACE-041, programs based on antibodies that bind to Activin A and/or Activin B, and programs based on antibodies that bind to BMP3, disclosed by Acceleron to the Observer provided that such information relating specifically to programs based on ActRIIB, such as ACE-031 and programs based on ALK-1, such as ACE-041 disclosed by Acceleron to the Observer after December 20, 2007 shall not be considered Scientific Information hereunder.", "snippet_links": [{"key": "financial-information", "type": "clause", "offset": [64, 85]}, {"key": "based-on", "type": "definition", "offset": [164, 172]}, {"key": "provided-that", "type": "clause", "offset": [446, 459]}, {"key": "such-information", "type": "definition", "offset": [460, 476]}, {"key": "after-december", "type": "clause", "offset": [629, 643]}], "hash": "90cba81c54518d286a15598fd4848eae", "id": 3}, {"size": 2, "samples": [{"hash": "cvd1cXZlL08", "uri": "/contracts/cvd1cXZlL08#scientific-information", "label": "Exclusive License Agreement (Gossamer Bio, Inc.)", "score": 29.9691982269, "published": true}, {"hash": "5qAP4azxs2S", "uri": "/contracts/5qAP4azxs2S#scientific-information", "label": "Exclusive License Agreement (Gossamer Bio, Inc.)", "score": 29.7748126984, "published": true}], "snippet": "means all Information relating to the Compound, Backup Compound, Asthma Compounds, Biomarkers or Licensed Products and comprising medical, toxicological, pharmacological, pre-clinical, clinical or chemical data; specifications; medical uses; adverse reactions; formulations; bioanalytical metrics; analytical and quality control data and methods; and all proprietary information intended for submission or submitted to relevant Regulatory Authorities to support a Regulatory Approval Application for and Regulatory Approval of the Licensed Products in the Licensed Product Field in any country in the world, all to the extent Controlled by a Party.", "snippet_links": [{"key": "all-information", "type": "clause", "offset": [6, 21]}, {"key": "relating-to", "type": "definition", "offset": [22, 33]}, {"key": "backup-compound", "type": "definition", "offset": [48, 63]}, {"key": "licensed-products", "type": "clause", "offset": [97, 114]}, {"key": "adverse-reactions", "type": "definition", "offset": [242, 259]}, {"key": "data-and-methods", "type": "clause", "offset": [329, 345]}, {"key": "proprietary-information", "type": "clause", "offset": [355, 378]}, {"key": "relevant-regulatory-authorities", "type": "definition", "offset": [419, 450]}, {"key": "regulatory-approval-application", "type": "definition", "offset": [464, 495]}, {"key": "approval-of", "type": "clause", "offset": [515, 526]}, {"key": "product-field", "type": "definition", "offset": [565, 578]}, {"key": "the-world", "type": "definition", "offset": [597, 606]}, {"key": "to-the-extent", "type": "clause", "offset": [612, 625]}, {"key": "by-a-party", "type": "clause", "offset": [637, 647]}], "hash": "ae4a72301413520984b9eff98aafe934", "id": 4}, {"size": 2, "samples": [{"hash": "aFuT7FG818n", "uri": "/contracts/aFuT7FG818n#scientific-information", "label": "License and Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "A8kiaOZQpL", "uri": "/contracts/A8kiaOZQpL#scientific-information", "label": "License and Supply Agreement (BeiGene, Ltd.)", "score": 28.8658447266, "published": true}], "snippet": "means all the scientific documentation and data on the Product that is Controlled by any member of the Celgene Group in connection with the Products including any such data related to clinical development activities or results.", "snippet_links": [{"key": "member-of-the", "type": "clause", "offset": [89, 102]}, {"key": "celgene-group", "type": "definition", "offset": [103, 116]}, {"key": "in-connection-with", "type": "clause", "offset": [117, 135]}, {"key": "the-products", "type": "clause", "offset": [136, 148]}, {"key": "related-to", "type": "definition", "offset": [173, 183]}, {"key": "clinical-development-activities", "type": "definition", "offset": [184, 215]}], "hash": "1beefc1d3844fa6e19ed6cb08a6e482f", "id": 5}, {"size": 2, "samples": [{"hash": "fDSsQ2ZQYu2", "uri": "/contracts/fDSsQ2ZQYu2#scientific-information", "label": "License Agreement (Salmedix Inc)", "score": 20.0, "published": true}, {"hash": "cK0ak3v6L4o", "uri": "/contracts/cK0ak3v6L4o#scientific-information", "label": "License Agreement (Salmedix Inc)", "score": 20.0, "published": true}], "snippet": "means any and all information, processes, techniques, data, know-how and trade secrets with respect to the Compound and/or the Product, including toxicological, pharmacological, pre-clinical, clinical and chemical data, specifications, medical uses, adverse reactions, formulation and quality control methods of the Compound and/or the Product.", "snippet_links": [{"key": "all-information", "type": "clause", "offset": [14, 29]}, {"key": "how-and-trade-secrets", "type": "clause", "offset": [65, 86]}, {"key": "with-respect-to", "type": "clause", "offset": [87, 102]}, {"key": "the-product", "type": "clause", "offset": [123, 134]}, {"key": "adverse-reactions", "type": "definition", "offset": [250, 267]}, {"key": "quality-control", "type": "clause", "offset": [285, 300]}], "hash": "9d192ca26d2eee9f1e0ab6632eaabcce", "id": 6}, {"size": 1, "samples": [{"hash": "7lsmmmF7Pzd", "uri": "https://www.dol.gov/asp/ideascale/si-policy-for-comment.pdf", "label": "www.dol.gov", "score": 10.1704311371, "published": false}], "snippet": "means factual inputs, data, models, analyses, technical information, or scientific assessments based on the behavioral and social sciences, public health and medical sciences, life and earth sciences, engineering, mathematics, statistics, or physical sciences. This includes any communication or representation of knowledge such as facts or data, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual forms. This definition includes information that an", "snippet_links": [{"key": "technical-information", "type": "definition", "offset": [46, 67]}, {"key": "based-on", "type": "definition", "offset": [95, 103]}, {"key": "social-sciences", "type": "clause", "offset": [123, 138]}, {"key": "medical-sciences", "type": "clause", "offset": [158, 174]}, {"key": "physical-sciences", "type": "definition", "offset": [242, 259]}], "hash": "26af8754b16e8c3f475cf7572f2b8fa2", "id": 7}, {"size": 1, "samples": [{"hash": "aRh2ZH2ESUB", "uri": "/contracts/aRh2ZH2ESUB#scientific-information", "label": "Exclusive Technology License Agreement (Energenx, Inc.)", "score": 21.0, "published": true}], "snippet": "means all Proprietary Information, Trade Secrets, Know-How and all information contained in existing Patents, Patent(s) that may issue or Patent Application(s) and Improvements that is the exclusive property of Licensor developed or acquired as of the date of this agreement which would be useful in the making, using and selling of the Licensed Products in the Licensed Territory.", "snippet_links": [{"key": "proprietary-information", "type": "clause", "offset": [10, 33]}, {"key": "trade-secrets", "type": "definition", "offset": [35, 48]}, {"key": "all-information", "type": "clause", "offset": [63, 78]}, {"key": "contained-in", "type": "definition", "offset": [79, 91]}, {"key": "existing-patents", "type": "definition", "offset": [92, 108]}, {"key": "property-of-licensor", "type": "clause", "offset": [199, 219]}, {"key": "date-of-this-agreement", "type": "definition", "offset": [252, 274]}, {"key": "licensed-products", "type": "clause", "offset": [337, 354]}, {"key": "licensed-territory", "type": "definition", "offset": [362, 380]}], "hash": "7811f3b38217f0e9daff46a2a06ff806", "id": 8}, {"size": 1, "samples": [{"hash": "5BUYgcz3WkW", "uri": "/contracts/5BUYgcz3WkW#scientific-information", "label": "Supply, Distribution and Licensing Agreement (Prima BioMed LTD)", "score": 25.7282676697, "published": true}], "snippet": "means all the scientific documentation and data on the Products that is required for Registration and the Reimbursement Approval, including any data related to clinical development activities or results.", "snippet_links": [{"key": "the-products", "type": "clause", "offset": [51, 63]}, {"key": "required-for-registration", "type": "clause", "offset": [72, 97]}, {"key": "reimbursement-approval", "type": "definition", "offset": [106, 128]}, {"key": "related-to", "type": "definition", "offset": [149, 159]}, {"key": "clinical-development-activities", "type": "definition", "offset": [160, 191]}], "hash": "452375ec1b57672b21642c71e7162a70", "id": 9}, {"size": 1, "samples": [{"hash": "cg3sqfoPOVF", "uri": "http://investor.acceleronpharma.com/index.php/static-files/cd1c908f-168c-4de4-a3ea-1b127d59afc7", "label": "investor.acceleronpharma.com", "score": 9.96235466, "published": false}], "snippet": "means any and all non-public scientific, technical, business or financial information, in whatever form (written, oral or visual) relating specifically to programs based on ActRIIA, such as ACE-011, programs based on", "snippet_links": [{"key": "financial-information", "type": "clause", "offset": [64, 85]}, {"key": "based-on", "type": "definition", "offset": [164, 172]}], "hash": "b05469f131e8e2b2df1327848baf8fb6", "id": 10}], "next_curs": "CmMSXWoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIfc2NpZW50aWZpYy1pbmZvcm1hdGlvbiMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 29, "title": "Scientific Information", "snippet": "means factual inputs, data, models, analyses, technical information, or scientific assessments related to such disciplines as the behavioral and social sciences, public health and medical sciences, life and earth sciences, engineering, or physical sciences. This definition includes any communication or representation of knowledge (e.g., facts or data, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual forms). This definition includes information that NRC disseminates from its Web page but does not include the provision of hyperlinks on a Web page to information that others disseminate. This definition excludes opinions where NRC\u2019s presentation makes clear that an individual\u2019s opinion, rather than a statement of fact or of the agency\u2019s findings and conclusions, is being offered.", "id": "scientific-information", "examples": ["As a non-employee consultant, you agree that, among other policies and guidelines, the GTE Conflict of Interest Guidelines and the Business and <strong>Scientific Information</strong> Policy or replacement policies will apply to you.", "For the avoidance of doubt, these obligations shall also extend to the members of the receiving party\u2019s Group and that may from time to time be granted or otherwise obtain access to or use of such Confidential Information, including all <strong>Scientific Information</strong>, Know-how and Other Confidential Information for the purpose of performing the Agreement.", "Pulmokine shall disclose to Licensee, at Pulmokine\u2019s cost and expense, the Licensed Know-How as Controlled by Pulmokine as of the Effective Date, including all <strong>Scientific Information</strong>, Data and other Information related to the Compound, the Backup Compound, the Asthma Compounds, Biomarkers and Licensed Products.", "The foregoing rights do not under any circumstances include any right for BeiGene or its designees to (i) manufacture the Product in or outside the Territory; or (ii) exercise in any way whatsoever any rights in or with respect to any Celgene tangible or intangible property (including the Patent, the Know-how, <strong>Scientific Information</strong> and other Celgene Intellectual Property) outside of the Territory or in any way within the Territory except as expressly set forth herein.", "The Right of First Negotiation shall in no way alter or affect F-DE\u2019s ownership rights in and to the <strong>Scientific Information</strong>, Data and/or the Product outside of the Territory.", "The JC shall coordinate the Parties\u2019 sharing of <strong>Scientific Information</strong> as required under this Agreement.", "Novan shall deliver to Sato copies of Novan <strong>Scientific Information</strong> that is necessary for the development, manufacture or commercialization of the Licensed Product in the Licensed Field in the Licensed Territory becomes available in tangible or written form after the Effective Date, as may be mutually agreed upon by the Parties.", "Celgene and the Observer will promptly return to Acceleron all Confidential Information that is <strong>Scientific Information</strong>, including all copies and reproductions thereof, to the extent required under the License Agreement.", "Through such committee, (i) F-DE will share with SALMEDIX all <strong>Scientific Information</strong> and Data generated or compiled by or on behalf of F-DE and (ii) SALMEDIX will share with F-DE <strong>Scientific Information</strong> and Data generated or compiled by or on behalf of SALMEDIX.", "The Party receiving such notice may elect in writing to bear the responsibility for such additional payments, and upon such receiving Party\u2019s written election to bear such responsibility, the Information, <strong>Scientific Information</strong>, or Patents as applicable, shall thereafter be deemed \u201cControlled\u201d by the Party originally obtaining such license or rights (notwithstanding Section 1.17), and shall be subject to the license under Section 2.1 or 2.3, as applicable."], "related": [["biometric-information", "Biometric information", "Biometric information"], ["genetic-information", "Genetic information", "Genetic information"], ["patient-information", "Patient Information", "Patient Information"], ["project-specific-information", "Project specific information", "Project specific information"], ["public-information", "Public Information", "Public Information"]], "related_snippets": [], "updated": "2025-09-18T04:40:28+00:00"}, "json": true, "cursor": ""}}